1. Home
  2. CADL vs IHRT Comparison

CADL vs IHRT Comparison

Compare CADL & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$11.27

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo iHeartMedia Inc.

IHRT

iHeartMedia Inc.

N/A

Current Price

$2.47

Market Cap

589.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
IHRT
Founded
1999
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
589.5M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
CADL
IHRT
Price
$11.27
$2.47
Analyst Decision
Strong Buy
Sell
Analyst Count
7
2
Target Price
$19.00
$4.25
AVG Volume (30 Days)
1.2M
384.1K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
54.19
EPS
N/A
N/A
Revenue
$125,000.00
$3,864,991,000.00
Revenue This Year
N/A
$9.96
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.27
52 Week Low
$4.35
$2.45
52 Week High
$14.00
$6.56

Technical Indicators

Market Signals
Indicator
CADL
IHRT
Relative Strength Index (RSI) 43.88 36.46
Support Level $4.91 $2.56
Resistance Level $11.36 $2.90
Average True Range (ATR) 0.70 0.13
MACD -0.34 0.03
Stochastic Oscillator 31.85 20.29

Price Performance

Historical Comparison
CADL
IHRT

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: